Federal Contract

Venus Thrombosis (VT)

See the original posting, the buyer’s contact details, and thousands more contracts like this one

Free account. Already have one? Log in

Get started

Agency

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

NAICS Code

541715

Department

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

Solicitation Type

Combined Synopsis/Solicitation

Solicitation #

80JSC026Q0014

PSC Code

AN22

Division

NASA JOHNSON SPACE CENTER

Performance State

TX

Posted

Fri, September 25, 2026

Response Deadline

Fri, November 20, 2026

Extended to Dec 4, 2026 by a later notice

Description

Venus Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venus Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition. All responsible sources may submit an offer which must be considered by the agency. Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination. The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference. The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price. F…

Notice history (7)

  1. Sep 25, 2026Combined Synopsis/SolicitationDue Nov 20, 2026Viewing
Show 3 earlier notices
  1. Sep 25, 2026Combined Synopsis/SolicitationDue Nov 20, 2026

    Venous Thrombosis (VT)

    Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition. All responsible sources may submit an offer which must be considered by the agency. Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination. The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incor

  2. Sep 28, 2026Combined Synopsis/SolicitationDue Nov 20, 2026

    Venous Thrombosis (VT)

    Amendment 002: The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition. All responsible sources may submit an offer which must be considered by the agency. Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination. The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf Offerors must provide the information required b

  3. Oct 28, 2026Combined Synopsis/SolicitationDue Nov 20, 2026

    Venous Thrombosis (VT)

    Amendment 003: The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers. We have also extended the question due date to close on 10/30/2026 at 1:00PM CST We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates. Amendment 002: The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition. All responsible sources may submit an offer which must be considered by the agency. Delivery to NASA/JSC is required within 30 days after

  1. Nov 9, 2026Combined Synopsis/SolicitationDue Nov 20, 2026

    Venous Thrombosis (VT)

    Amendment 004: The purpose of this amendment is to update the "Attachment E - Questions and Answers 11.09.26" to include more questions and responses. If you don't see you questions word for word, questions may have been generalized, combined, or altered to protect proper protocols. Amendment 003: The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers. We have also extended the question due date to close on 10/30/2026 at 1:00PM CST We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates. Amendment 002: The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS

  2. Nov 16, 2026Combined Synopsis/SolicitationDue Dec 4, 2026

    Venous Thrombosis (VT)

    Amendment 005: The purpose of this amendment is to extend the response due date from 11/20/2026 to 12/04/2026. Amendment 004: The purpose of this amendment is to update the "Attachment E - Questions and Answers 11.09.26" to include more questions and responses. If you don't see you questions word for word, questions may have been generalized, combined, or altered to protect proper protocols. Amendment 003: The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers. We have also extended the question due date to close on 10/30/2026 at 1:00PM CST We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates. Amendment 002: The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Ve

  3. Nov 17, 2026Combined Synopsis/SolicitationDue Dec 4, 2026

    Venous Thrombosis (VT)

    Amendment 006: The purpose of this amendment is to update the "Attachment E - Questions and Answers 11.17.26" & add clause "52.240-90 | Security Prohibitions and Exclusions Representations and Certifications". Amendment 005: The purpose of this amendment is to extend the response due date from 11/20/2026 to 12/04/2026. Amendment 004: The purpose of this amendment is to update the "Attachment E - Questions and Answers 11.09.26" to include more questions and responses. If you don't see you questions word for word, questions may have been generalized, combined, or altered to protect proper protocols. Amendment 003: The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers. We have also extended the question due date to close on 10/30/2026 at 1:00PM CST We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates. Amendment 002: The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constit

Similar open contracts